Project Seagrass: Donating fees to save our seas
PK/PD of Antimicrobial Agents: Get it right or expect a rough ride
Aducanumab: Breaking through, or moving the goalposts…?
tranScrip welcomes Senior Partner, Richard Vickers
We're ready for ASCO 2021
Another development milestone as Synairgen announce results of in vitro studies which demonstrates antiviral activity against two SARS-CoV-2 variants
Clinical Trials Day 2021
tranScrip is delighted to join the One Nucleus Partner Programme